Bioxytran Receives Approval to Initiate Trials with ProLectin-I
BOSTON, MASSACHUSETTS, Feb. 06, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a…
Month: February 2023
Ashvattha Therapeutics Announces First Patient Enrolled in a Phase 1 Study of [18F]OP-801 for Use as Imaging Agent
– The study will evaluate the safety, tolerability and ability of [18F]OP-801 to cross the…
Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California
SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Revolo Biotherapeutics to Present Recently Generated Data at the 2023 AAAAI Annual Meeting Demonstrating Anti-inflammatory Effect of ‘1104 in Food Allergy
NEW ORLEANS and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo” or the…
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the…
PDS Biotech Announces Abstract Accepted for Presentation at ESMO Targeted Anticancer Therapies Congress
Abstract, titled “HPV16-specific CD4 and CD8 T cell activation and functionality in patients receiving combination…
Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
BOSTON and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…
Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer
MELBOURNE, Australia, Feb. 06, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
NewAmsterdam Pharma Appoints John W. Smither to its Board of Directors
NAARDEN, The Netherlands and MIAMI, Feb. 06, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….
CymaBay Therapeutics to Present at the SVB Securities Global Biopharma Conference
NEWARK, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC
Media Release 20 patients with 1st line non-small cell lung cancer (1L NSCLC) now enrolled…
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
SANTA MONICA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced…
ORYZON to Give Updates on Corporate Progress in February-March
BIO CEO & Investor Conference 2023 IASLC 2023 Targeted Therapies of Lung Cancer Meeting 16th…
PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics
PharmAla Biotech will provide MDMA to Revive Therapeutics in their development of an MDMA Microneedle…
Vincerx Pharma to Participate at the SVB Securities Global Biopharma Conference
PALO ALTO, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE…
Oncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell Cancer
AGOURA HILLS, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
aTyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd.
$10M milestone payment triggered by advancement of clinical program in Japan. Multiple centers in the…